-
Mashup Score: 71Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension – Recor Medical - 6 month(s) ago
Approval of the Paradise™ Ultrasound Renal Denervation system makes innovative hypertension treatment available for the first time in the U.S.Palo Alto, Calif. – November 7, 2023 – Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) today announced the U.S. Food and Drug Administration (FDA) has approved Recor’s Paradise™ Ultrasound…
Source: www.recormedical.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 70Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension – Recor Medical - 6 month(s) ago
Approval of the Paradise™ Ultrasound Renal Denervation system makes innovative hypertension treatment available for the first time in the U.S.Palo Alto, Calif. – November 7, 2023 – Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) today announced the U.S. Food and Drug Administration (FDA) has approved Recor’s Paradise™ Ultrasound…
Source: www.recormedical.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 68Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension – Recor Medical - 6 month(s) ago
Approval of the Paradise™ Ultrasound Renal Denervation system makes innovative hypertension treatment available for the first time in the U.S.Palo Alto, Calif. – November 7, 2023 – Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) today announced the U.S. Food and Drug Administration (FDA) has approved Recor’s Paradise™ Ultrasound…
Source: www.recormedical.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 68Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension – Recor Medical - 6 month(s) ago
Approval of the Paradise™ Ultrasound Renal Denervation system makes innovative hypertension treatment available for the first time in the U.S.Palo Alto, Calif. – November 7, 2023 – Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) today announced the U.S. Food and Drug Administration (FDA) has approved Recor’s Paradise™ Ultrasound…
Source: www.recormedical.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 1Instagram - 9 month(s) ago
Palo Alto, Calif. – August 22, 2023 – Recor Medical, Inc. (“Recor”) and its parent company, Otsuka Medical Devices Co., Ltd. (“Otsuka Medical Devices”) announce the U.S. Food and Drug Administration (FDA) Circulatory Systems Devices Panel of the Medical Devices Advisory Committee met to discuss the pre-market approval application (PMA) for the Paradise™ Ultrasound Renal Denervation (RDN) system, indicated to reduce blood pressure in patients with hypertension. The overall vote from the committee was
Source: www.recormedical.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Recor – Ultrasound Denervation Product - 1 year(s) ago
Ultrasound Denervation Product
Source: www.recormedical.comCategories: Cardiologists, Latest HeadlinesTweet-
Proud that S. Maria Goretti Hospital in Latina is the 1st institution in Italy to perform a case of renal ultrasound denervation with the Paradise device, masterfully performed by Prof. Francesco Versaci and Dr. Iginio Colaiori https://t.co/hhboKDZdwf @ReCorMedical @RADIANCE_HTN https://t.co/dDycmVt8wf
-
-
Mashup Score: 0Clinical Results - 3 year(s) ago
Paradise Renal Denervation System Clinical Evidence Azizi et al. Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single- blind, sham-controlled trial. Lancet. 2021. In press Azizi et al. Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control Following Randomization to Endovascular…
Source: www.recormedical.comCategories: Cardiology News and Journals, Latest HeadlinesTweet
And just like that…renal denervation (ultrasound, Paradise/Recor) is FDA-approved A therapy in search of the adequate patients https://t.co/pS4tk0bne5 @AnastasiaSMihai @mvaduganathan @SJGreene_md @ChristosArgyrop @Nephro_Sparks @jbrianbyrd @brendonneuen @kidney_boy https://t.co/tPq8TbSRpA